Austar Lifesciences Limited (HKG:6118)

Revenue by Segment

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Inter-Segment Revenue	-314.94M	-278.51M	-275.54M	-306.82M	-164.80M
Life Science Equipment and Consumables	329.65M	346.16M	321.78M	391.81M	428.39M
Life Science Equipment and Consumables Growth	-4.77%	7.58%	-17.87%	-8.54%	68.32%
Consulting,digitalization and Construction	509.58M	611.42M	732.65M	-	-
Consulting,digitalization and Construction Growth	-16.66%	-16.55%	-	-	-
Integrated Process and Packaging Systems	1.01B	821.33M	984.85M	-	-
Integrated Process and Packaging Systems Growth	22.53%	-16.60%	-	-	-
Liquid and Bioprocess System	-	-	-	962.06M	970.10M
Liquid and Bioprocess System Growth	-	-	-	-0.83%	52.86%
Clean Room and Automation Control and Monitoring System	-	-	-	678.64M	537.76M
Clean Room and Automation Control and Monitoring System Growth	-	-	-	26.20%	77.21%
Powder and Solid System	-	-	-	293.03M	140.21M
Powder and Solid System Growth	-	-	-	109.00%	16.04%
GMP Compliance Service	-	-	-	98.86M	72.63M
GMP Compliance Service Growth	-	-	-	36.11%	30.64%
Distribution and Agency of Pharmaceutical Equipment	-	-	-	39.29M	30.75M
Distribution and Agency of Pharmaceutical Equipment Growth	-	-	-	27.78%	47.83%
Total	1.53B	1.50B	1.76B	2.16B	2.02B
Total Growth	2.02%	-14.93%	-18.23%	7.04%	55.48%

Revenue by Geography

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Mainland China	1.33B	1.33B	1.68B	2.07B	1.89B
Mainland China Growth	0.09%	-20.68%	-18.93%	9.67%	55.10%
Other Locations	196.01M	166.92M	82.64M	83.31M	124.37M
Other Locations Growth	17.43%	101.99%	-0.81%	-33.02%	61.60%
Total	1.53B	1.50B	1.76B	2.16B	2.02B
Total Growth	2.02%	-14.93%	-18.23%	7.04%	55.48%

Data Source: S&P Global Market Intelligence Last updated: Dec 31, 2025

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Jun 20, 2026

Data Sources Report a data error